abstract |
This disclosure concerns the isolation, identification and sequencing of a unique Phlebovirus , the Lone Star Virus. Lone Star Virus nucleic acid molecules, proteins and antibodies are disclosed. Methods are also disclosed for the detection, diagnostic and treatment of the Lone Star Virus. |